Adolescent Obesity
Conditions
Keywords
obesity, adolescent, tracking device, fitbit
Brief summary
This study will evaluate whether the short-term use of activity tracking devices improves short-term weight loss in adolescents. The investigators will evaluate whether weight loss translates into a change in obesity-related biomarkers associated with adolescent obesity. In addition, the investigators will report outcomes after the implementation of activity tracking devices in conjunction with an intense adolescent weight loss program.
Detailed description
This study will evaluate the short-term use of activity tracking devices and their effects on short- and long-term weight loss in adolescents. The investigators plan to establish whether weight loss translates into a change in obesity-related biomarkers associated with adolescent obesity. Each participant with an activity tracking device will have the goal of reaching 10,000 steps per day, in addition to their individual fitness plan.
Interventions
BEHAVIORALActivity Tracker
Fitbit Alta
Sponsors
The University of Texas Medical Branch, Galveston
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
Ages 12-18 years BMI ≥ 95th percentile for age and sex group Participant able to read and understand English Willingness to be randomized to any condition
Exclusion criteria
Inability to obtain informed parental consent and/or child assent Inability to participate in the program due to pre-existing conditions (e.g., paralysis, heart failure, severe autism or mental retardation, psychosis) Pregnancy Clinical judgment concerning safety Inability of the participant to speak English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of the pilot trial will be measured by an attrition rate of ≤50%. | 18 weeks | We set a study attrition rate of participants at ≤50% as the feasibility measure for the study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body mass index (BMI) (kg/m2) | Change from 0 to 18 weeks | Absolute change in BMI |
| Weight (kg) | Change from 0 to 18 weeks | Weight change |
| Change in obesity related biomarkers | Change from 0 to 18 weeks | AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl transferase; CRP: C reactive protein |
Countries
United States
Outcome results
None listed